USD 0.65
(-9.08%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 29.54 Million USD | 5.32% |
2022 | 28.04 Million USD | 9672.82% |
2021 | 287 Thousand USD | -46.05% |
2020 | 532 Thousand USD | -31.09% |
2019 | 772 Thousand USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | -100.0% |
2015 | 2.35 Million USD | -14.51% |
2014 | 2.75 Million USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 30.63 Million USD | 0.65% |
2024 Q1 | 30.43 Million USD | 3.03% |
2023 Q4 | 29.54 Million USD | -1.28% |
2023 FY | 29.54 Million USD | 5.32% |
2023 Q1 | 26.37 Million USD | -5.98% |
2023 Q3 | 29.92 Million USD | -0.67% |
2023 Q2 | 30.12 Million USD | 14.24% |
2022 Q2 | 23.25 Million USD | 8842.31% |
2022 Q3 | 25.13 Million USD | 8.1% |
2022 Q4 | 28.04 Million USD | 11.6% |
2022 FY | 28.04 Million USD | 9672.82% |
2022 Q1 | 260 Thousand USD | -9.41% |
2021 Q3 | 359 Thousand USD | -17.66% |
2021 Q1 | 499 Thousand USD | -6.2% |
2021 Q4 | 287 Thousand USD | -20.06% |
2021 Q2 | 436 Thousand USD | -12.63% |
2021 FY | 287 Thousand USD | -46.05% |
2020 FY | 532 Thousand USD | -31.09% |
2020 Q1 | 671 Thousand USD | -13.08% |
2020 Q2 | 606 Thousand USD | -9.69% |
2020 Q3 | 543 Thousand USD | -10.4% |
2020 Q4 | 532 Thousand USD | -2.03% |
2019 Q2 | 786 Thousand USD | -3.79% |
2019 FY | 772 Thousand USD | 0.0% |
2019 Q3 | 764 Thousand USD | -2.8% |
2019 Q4 | 772 Thousand USD | 1.05% |
2019 Q1 | 817 Thousand USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | -100.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | -100.0% |
2015 FY | 2.35 Million USD | -14.51% |
2015 Q4 | 2.36 Million USD | 0.0% |
2015 Q3 | 2.36 Million USD | 0.0% |
2015 Q2 | 2.36 Million USD | -11.28% |
2015 Q1 | 2.66 Million USD | -3.62% |
2014 Q1 | - USD | 0.0% |
2014 FY | 2.75 Million USD | 0.0% |
2014 Q4 | 2.76 Million USD | -52.25% |
2014 Q3 | 5.78 Million USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Bionano Genomics, Inc. | 87.94 Million USD | 66.41% |
Prenetics Global Limited | 2.36 Million USD | -1146.778% |
Star Equity Holdings, Inc. | 3.6 Million USD | -718.537% |
CareDx, Inc | 34.22 Million USD | 13.676% |
Exact Sciences Corporation | 2.55 Billion USD | 98.844% |
Exagen Inc. | 23.72 Million USD | -24.535% |
Inotiv, Inc. | 417.64 Million USD | 92.927% |
Guardant Health, Inc. | 1.35 Billion USD | 97.818% |
Biodesix, Inc. | 60.69 Million USD | 51.326% |
BioNexus Gene Lab Corp. | 133.39 Thousand USD | -22045.508% |
Precipio, Inc. | 1.11 Million USD | -2547.043% |
iSpecimen Inc. | 196.24 Thousand USD | -14953.199% |
Natera, Inc. | 441.99 Million USD | 93.316% |
Aspira Women's Health Inc. | 2.26 Million USD | -1203.663% |
Standard BioTools Inc. | 98.21 Million USD | 69.921% |
23andMe Holding Co. | 76.51 Million USD | 61.392% |
Castle Biosciences, Inc. | 15.31 Million USD | -92.952% |
Personalis, Inc. | 48.96 Million USD | 39.665% |
Aclaris Therapeutics, Inc. | 426 Thousand USD | -6834.507% |
Applied DNA Sciences, Inc. | 1.23 Million USD | -2286.65% |
OpGen, Inc. | 13.04 Million USD | -126.477% |
T2 Biosystems, Inc. | 49.49 Million USD | 40.319% |
Myriad Genetics, Inc. | 145 Million USD | 79.627% |
ICON Public Limited Company | 3.93 Billion USD | 99.25% |
NeoGenomics, Inc. | 611.67 Million USD | 95.171% |
Star Equity Holdings, Inc. | 3.6 Million USD | -718.537% |
IDEXX Laboratories, Inc. | 947.88 Million USD | 96.883% |
RadNet, Inc. | 1.49 Billion USD | 98.019% |
MDxHealth SA | 41.26 Million USD | 28.411% |
Psychemedics Corporation | 2.29 Million USD | -1185.509% |
Illumina, Inc. | 2.26 Billion USD | 98.694% |
Check-Cap Ltd. | - USD | -Infinity% |
Twist Bioscience Corporation | 94.06 Million USD | 68.596% |
Fulgent Genetics, Inc. | 14.9 Million USD | -98.169% |
Sera Prognostics, Inc. | 1.85 Million USD | -1489.935% |
ENDRA Life Sciences Inc. | 394.4 Thousand USD | -7390.055% |
OPKO Health, Inc. | 326.56 Million USD | 90.954% |
Medpace Holdings, Inc. | 142.12 Million USD | 79.214% |
Neogen Corporation | 906.23 Million USD | 96.74% |
Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -3289.906% |
Prenetics Global Limited | 2.36 Million USD | -1146.778% |
Mainz Biomed B.V. | 7.42 Million USD | -298.085% |
bioAffinity Technologies, Inc. | 1.57 Million USD | -1771.295% |
Trinity Biotech plc | 67.42 Million USD | 56.188% |
Neuronetics, Inc. | 62.47 Million USD | 52.715% |
Sotera Health Company | 2.32 Billion USD | 98.731% |
bioAffinity Technologies, Inc. | 1.57 Million USD | -1771.295% |